ArticleCirculation2026

SGLT2 Inhibitor Empagliflozin Reduces Circulating Monocyte-Platelet Aggregates: A Pilot Study.

B Ilkin Safa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.